BKR:NASDAQBaker Hughes Company Analysis
Data as of 2026-05-19 - not real-time
$65.47
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Baker Hughes delivered a Q1 2026 revenue of $6.59 billion, a 2.5% YoY increase, and beat earnings expectations, sparking a 4.7% intraday rally. The company’s operating margin of 12.3% and profit margin of 11.2% remain solid, while free cash flow of $3.15 billion supports a 1.39% dividend at a modest 29% payout. On the chart, the stock trades at $65.47, comfortably above the 20‑day SMA of 66.3 and the 50‑day SMA of 62.7, with the 200‑day SMA at 53.1, indicating a bullish long‑term trend. Momentum is mixed: the RSI sits near 52 (neutral) and the MACD histogram is negative, signaling short‑term bearish pressure, while volume is trending lower, suggesting reduced buying enthusiasm.
Valuation is nuanced; the forward PE of 23.5 is slightly below the industry average of 22.3, yet the DCF fair value of $45.6 places the current price well above intrinsic estimates, hinting at a possible premium. The stock’s beta of ~0.76 and 30‑day volatility of 35% point to moderate market sensitivity, and the dividend appears sustainable given strong cash generation. Overall, the fundamentals, earnings beat, and dividend make the stock attractive, but the technical pullback and elevated price relative to DCF counsel a measured approach.
Valuation is nuanced; the forward PE of 23.5 is slightly below the industry average of 22.3, yet the DCF fair value of $45.6 places the current price well above intrinsic estimates, hinting at a possible premium. The stock’s beta of ~0.76 and 30‑day volatility of 35% point to moderate market sensitivity, and the dividend appears sustainable given strong cash generation. Overall, the fundamentals, earnings beat, and dividend make the stock attractive, but the technical pullback and elevated price relative to DCF counsel a measured approach.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Q1 earnings beat and revenue growth
- Bullish long‑term trend above 200‑day SMA
- Neutral RSI with price near support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable dividend yield and low payout ratio
- Strong free cash flow and operating margins
- Analyst consensus of "buy" and positive earnings momentum
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Exposure to cyclical energy sector and transition risk
- Solid cash generation supporting dividend continuity
- Current price premium to DCF fair value suggests limited upside
Key Metrics & Analysis
Financial Health
Revenue Growth2.50%
Profit Margin11.17%
P/E Ratio20.9
ROE17.18%
ROA5.01%
Debt/Equity82.94
P/B Ratio3.4
Op. Cash Flow$3.6B
Free Cash Flow$3.2B
Industry P/E22.3
Technical Analysis
TrendBullish
RSI52.6
Support$60.96
Resistance$70.41
MA 20$66.31
MA 50$62.75
MA 200$53.05
MACDBearish
VolumeDecreasing
Fear & Greed Index89.18
Valuation
Fair Value$45.56
Target Price$70.57
Upside/Downside7.79%
GradeFair
TypeBlend
Dividend Yield1.39%
Risk Assessment
Beta0.76
Volatility35.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.